Minyoung Jang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Minyoung Jang has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Dimitrios Nasioudis
University of Pennsylvania, Division of Gynecologic Oncology, Philadelphia, PA, USA
4 shared publications Christian Dagher
Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, PA, USA
2 shared publicationsEmily M. Ko
University of Pennsylvania, Division of Gynecologic Oncology, Philadelphia, PA, USA
2 shared publicationsSarah H. Kim
University of Pennsylvania, Division of Gynecologic Oncology, Philadelphia, PA, USA
2 shared publicationsStefan Gysler
University of Pennsylvania, Division of Gynecologic Oncology, Philadelphia, PA, USA
2 shared publications- Andrew D. Zale
Division of Hematologic Malignancies, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
1 shared publication
Latest Publications
- Open Access
- 2 March 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (3) , 102818
De-escalation in stage IC epithelial ovarian cancer: adjuvant treatment
- 2 March 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (3) , 102818
Open AccessDe-escalation in stage IC epithelial ovarian cancer: adjuvant treatment
- Open Access
Advances in the Surgical Management of Cervical Cancer
Cervical cancer is the third most common gynecologic malignancy in the United States. Traditionally, a radical hysterectomy with bilateral salpingo-oophorectomy with lymph node assessment had been the standard of care; however, there has been a recent shift towards less radical surgery with the establishment of the oncologic safety of conization (as fertility preserving surgery), and simple hysterectomy for certain subgroups of patients with early-stage disease. In addition, uptake in the utilization of sentinel lymph node mapping, compared to systematic lymphadenectomy, has translated to improved perioperative outcomes. While laparotomy is the preferred mode of surgery for patients with cervical cancer, emerging data suggest that protective maneuvers may not compromise oncologist outcomes and multiple clinical trials are evaluating the oncologic safety of minimally invasive surgery. In this present review, we summarize recent advances in surgical management in patients with cervical cancer.
Open AccessAdvances in the Surgical Management of Cervical Cancer
Cervical cancer is the third most common gynecologic malignancy in the United States. Traditionally, a radical hysterectomy with bilateral salpingo-oophorectomy with lymph node assessment had been the standard of care; however, there has been a recent shift towards less radical surgery with the establishment of the oncologic safety of conization (as fertility preserving surgery), and simple hysterectomy for certain subgroups of patients with early-stage disease. In addition, uptake in the utilization of sentinel lymph node mapping, compared to systematic lymphadenectomy, has translated to improved perioperative outcomes. While laparotomy is the preferred mode of surgery for patients with cervical cancer, emerging data suggest that protective maneuvers may not compromise oncologist outcomes and multiple clinical trials are evaluating the oncologic safety of minimally invasive surgery. In this present review, we summarize recent advances in surgical management in patients with cervical cancer.
- Open Access
- 25 November 2025
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 62
Ovarian carcinoid tumor with carcinoid heart syndrome: A case report and literature review
- 25 November 2025
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 62
Open AccessOvarian carcinoid tumor with carcinoid heart syndrome: A case report and literature review
- Open Access
- 22 November 2025
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (2) , 102824
Early administration of adjuvant chemotherapy for patients with advanced-stage malignant ovarian germ cell tumors is associated with an overall survival benefit
- 22 November 2025
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (2) , 102824
Open AccessEarly administration of adjuvant chemotherapy for patients with advanced-stage malignant ovarian germ cell tumors is associated with an overall survival benefit
- Open Access
- 21 November 2025
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (2) , 102816
Incidence of ESR1 gene mutations among patients with endometrioid endometrial cancer
- 21 November 2025
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (2) , 102816
Open AccessIncidence of ESR1 gene mutations among patients with endometrioid endometrial cancer
- 1 November 2021
- Published by Elsevier in Journal of Surgical Education
- Vol. 78 (6) , 1825-1837
A Qualitative Study of the Barriers and Benefits to Resident Education in Ambulatory Surgical Centers
- 1 November 2021
- Published by Elsevier in Journal of Surgical Education
- Vol. 78 (6) , 1825-1837
A Qualitative Study of the Barriers and Benefits to Resident Education in Ambulatory Surgical Centers
- Open Access
- 17 July 2020
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 84 (5) , e13306
COVID‐19 in pregnancy: Placental and neonatal involvement
Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has caused over 12 million infections and more than 550 000 deaths.1 Morbidity and mortality appear partly due to host inflammatory response.2 Despite rapid, global research, the effect of SARS‐CoV‐2 on the developing fetus remains unclear. Case reports indicate that vertical transmission is uncommon; however, there is evidence that placental and fetal infection can occur.3‐7 Placentas from infected patients show inflammatory, thrombotic, and vascular changes that have been found in other inflammatory conditions.8,9 This suggests that the inflammatory nature of SARS‐CoV‐2 infection during pregnancy could cause adverse obstetric and neonatal events. Exposure to intrauterine inflammation and placental changes could also potentially result in long‐term, multisystemic defects in exposed infants. This review will summarize the known literature on the placenta in SARS‐CoV‐2 infection, evidence of vertical transmission, and possible outcomes of prenatal exposure to the virus.
- 17 July 2020
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 84 (5) , e13306
Open AccessCOVID‐19 in pregnancy: Placental and neonatal involvement
Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has caused over 12 million infections and more than 550 000 deaths.1 Morbidity and mortality appear partly due to host inflammatory response.2 Despite rapid, global research, the effect of SARS‐CoV‐2 on the developing fetus remains unclear. Case reports indicate that vertical transmission is uncommon; however, there is evidence that placental and fetal infection can occur.3‐7 Placentas from infected patients show inflammatory, thrombotic, and vascular changes that have been found in other inflammatory conditions.8,9 This suggests that the inflammatory nature of SARS‐CoV‐2 infection during pregnancy could cause adverse obstetric and neonatal events. Exposure to intrauterine inflammation and placental changes could also potentially result in long‐term, multisystemic defects in exposed infants. This review will summarize the known literature on the placenta in SARS‐CoV‐2 infection, evidence of vertical transmission, and possible outcomes of prenatal exposure to the virus.